These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36440399)

  • 61. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.
    Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS
    Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy and cost-effectiveness of therapist-guided internet-delivered behaviour therapy for children and adolescents with Tourette syndrome: study protocol for a single-blind randomised controlled trial.
    Andrén P; Fernández de la Cruz L; Isomura K; Lenhard F; Hall CL; Davies EB; Murphy T; Hollis C; Sampaio F; Feldman I; Bottai M; Serlachius E; Andersson E; Mataix-Cols D
    Trials; 2021 Sep; 22(1):669. PubMed ID: 34593015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA; Stebbins GT; Siegel S; Schultz TM; Hays C; Morrissey MJ; Leurgans S; Goetz CG
    Mov Disord; 2009 May; 24(7):1070-3. PubMed ID: 19306279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relationship of serum ferritin level and tic severity in children with Tourette syndrome.
    Ghosh D; Burkman E
    Childs Nerv Syst; 2017 Aug; 33(8):1373-1378. PubMed ID: 28470381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM
    J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effectiveness of Behaviour Therapy for Children and Adolescents with Tourette Syndrome and Chronic Tic Disorder in a Naturalistic Setting.
    Andrén P; Wachtmeister V; Franzé J; Speiner C; Fernández de la Cruz L; Andersson E; de Schipper E; Rautio D; Silverberg-Mörse M; Serlachius E; Mataix-Cols D
    Child Psychiatry Hum Dev; 2021 Aug; 52(4):739-750. PubMed ID: 33315190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Environmental circumstances influencing tic expression in children.
    Caurín B; Serrano M; Fernández-Alvarez E; Campistol J; Pérez-Dueñas B
    Eur J Paediatr Neurol; 2014 Mar; 18(2):157-62. PubMed ID: 24210363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tic-related activity restriction as a predictor of emotional functioning and quality of life.
    Conelea CA; Busch AM; Catanzaro MA; Budman CL
    Compr Psychiatry; 2014 Jan; 55(1):123-9. PubMed ID: 24156871
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pilot Testing Behavior Therapy for Chronic Tic Disorders in Neurology and Developmental Pediatrics Clinics.
    Ricketts EJ; Gilbert DL; Zinner SH; Mink JW; Lipps TD; Wiegand GA; Vierhile AE; Ely LJ; Piacentini J; Walkup JT; Woods DW
    J Child Neurol; 2016 Mar; 31(4):444-50. PubMed ID: 26271790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of Tiapride and Topiramate on Tic Severity and Behavioral/Emotional Problems in Children with Tourette Syndrome: A Retrospective Study.
    Zhou X; Liao Z; Li Y; Wang N; Xiao N
    Brain Sci; 2023 Feb; 13(3):. PubMed ID: 36979193
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial.
    Guo SX; Li RB; Hu SY; Cai QH; Zhong CL; Hao RM
    Trials; 2022 Oct; 23(1):898. PubMed ID: 36273181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of Parent-Delivered, Home-Based Therapy for Tics.
    Singer HS; McDermott S; Ferenc L; Specht M; Mahone EM
    Pediatr Neurol; 2020 May; 106():17-23. PubMed ID: 32165032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effectiveness of 'Tackle Your Tics', a brief, intensive group-based exposure therapy programme for children with tic disorders: study protocol of a randomised controlled trial.
    Heijerman-Holtgrefe A; Huyser C; Verdellen C; van de Griendt J; Beljaars L; Kan KJ; Lindauer R; Cath D; Hoekstra P; Utens L
    BMJ Open; 2022 Jun; 12(6):e058534. PubMed ID: 35768093
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome: a randomized controlled trial.
    Zheng Y; Zhang ZJ; Han XM; Ding Y; Chen YY; Wang XF; Wei XW; Wang MJ; Cheng Y; Nie ZH; Zhao M; Zheng XX
    J Child Psychol Psychiatry; 2016 Jan; 57(1):74-83. PubMed ID: 26072932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Self-initiated coping with Tourette's syndrome: Effect of tic suppression on QOL.
    Matsuda N; Kono T; Nonaka M; Fujio M; Kano Y
    Brain Dev; 2016 Feb; 38(2):233-41. PubMed ID: 26360257
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation between premonitory urges and tic symptoms in a Chinese population with tic disorders.
    Gu Y; Li Y; Cui Y
    Pediatr Investig; 2020 Jun; 4(2):86-90. PubMed ID: 32851350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Sociodemographic/Clinical characteristics and risk factors associated with chronic tic disorders].
    Hesapçıoğlu ST; Tural MK; Kandil S
    Turk Psikiyatri Derg; 2013; 24(3):158-67. PubMed ID: 24049006
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quality of Life Among Children and Adolescents With Tourette Disorder and Comorbid ADHD: A Clinical Controlled Study.
    Erbilgin Gün S; Kilincaslan A
    J Atten Disord; 2019 Jun; 23(8):817-827. PubMed ID: 29707998
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and efficacy of aripiprazole for the treatment of pediatric Tourette syndrome and other chronic tic disorders.
    Cox JH; Seri S; Cavanna AE
    Pediatric Health Med Ther; 2016; 7():57-64. PubMed ID: 29388585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.